Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Titel:
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Auteur:
Bang, Y.-J Ruiz, E.Yañez Van Cutsem, E. Lee, K.-W Wyrwicz, L. Schenker, M. Alsina, M. Ryu, M.-H Chung, H.-C Evesque, L. Al-Batran, S.-E Park, S.H. Lichinitser, M. Boku, N. Moehler, M.H. Hong, J. Xiong, H. Hallwachs, R. Conti, I. Taieb, J.